ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "BioScrip, Inc." (BIOS) Report Updated: Sep 26, 2016 | Print This Page

Get more stock ratings by Louis Navellier

"BioScrip, Inc." (BIOS)

Rating: Hold Volatility: Moderate
Total Grade: C Industry: Health Care Providers & Services
Competitors: USMD,DGX,PMD,HWAY

Stock Analysis

Rating: Monthly View

A
B
C
D
F
September October November December January February March April May June July August

Rating: Weekly View

This Week: C down no change
Last Week: C same no change
Two Weeks Ago: C up no change
service keys

"BioScrip, Inc."© quotemedia

Company Profile

BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit management (PBM) services in the United States. It operates in two segments, Infusion Services and PBM Services. The Infusion Services segment offers home infusion therapy and respiratory therapy services; and durable medical equipment, products, and services. Its services comprise home infusion services, including intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care; dispensing and administering of infusion-based drugs, which require nursing support and clinical management services; equipment to administer the dosage; and patient training. The PBM Services segment offers discount card programs that provide an alternative for individuals who may be uninsured, underinsured, or might have restrictive coverage, which disallows reimbursement for certain medications. The company was founded in 1993 and is based in Eden Prairie, Minnesota.